Research ArticleCancer

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

See allHide authors and affiliations

Science Translational Medicine  19 Feb 2020:
Vol. 12, Issue 531, eaax2625
DOI: 10.1126/scitranslmed.aax2625
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article